CDMO

Avid Bioservices Inc.

Price

return (12m)

0.00%

p/e

-5.26

p/bv

17.84

DIVIDEND YIELD

0.00%

CDMO price

Avid Bioservices

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment CDMO

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals CDMO

Valuation

P/E

-5.26

Sector -3.98

Industry -3.98

P/BV

17.84

Sector 2.00

Industry 2.00

P/Revenue (PSR)

5.31

Sector -4.41

Industry -4.41

EV/EBITDA

-90.56

Sector -245.01

Industry -245.01

EV/EBIT

-65.12

Sector -666.51

Industry -666.51

P/EBITDA

-55.70

Sector -4.07

Industry -4.07

P/EBIT

-29.82

Sector -4.24

Industry -4.24

P/Total Assets

2.47

Sector 1.40

Industry 1.40

P/Net Current Assets

-4.39

Sector -11.65

Industry -11.65

P/Working Capital

35.77

Sector -10.95

Industry -10.95

EPS

-2.38

Sector -2.20

Industry -2.20

BVPS

0.70

Sector 1.95

Industry 1.95

Efficiency

Gross Margin

7.68%

Sector 36.05%

Industry 36.05%

EBITDA Margin

-30.35%

Sector -16,817.20%

Industry -16,817.20%

EBIT Margin

-42.20%

Sector -4,256,841.62%

Industry -4,256,841.62%

Operating Margin

-13.55%

Sector -38.74%

Industry -38.74%

Net Profit Margins

-100.00%

Sector -39.50%

Industry -39.50%

Asset Turnover

0.10

Sector 0.03

Industry 0.03

Profitability

ROE

-339.32%

Sector -66.41%

Industry -66.41%

ROA

-47.00%

Sector -66.55%

Industry -66.55%

ROIC

-17.60%

Sector -1,703.97%

Industry -1,703.97%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

1.30

Sector 2.90

Industry 2.90

Net Debt / EBITDA

-11.88

Sector -14.63

Industry -14.63

Net Debt / EBIT

-8.54

Sector -7.24

Industry -7.24

Net Debt / Equity

2.69

Sector -33,201.65

Industry -33,201.65

Gross Debt / Equity

3.44

Sector -0.02

Industry -0.02

Equity/Assets

0.14

Sector 0.42

Industry 0.42

Liabilities/Assets

0.86

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

7.33%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals CDMO

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
CDMO	-5.26	17.84	-339.32%	0.00%	$799.36 M	-100.00%
JNJ	29.40	7.28	24.76%	2.04%	$618.44 B	21.48%
PFE	18.75	1.55	8.29%	6.97%	$140.44 B	11.83%
ABBV	71.07	0.00	-%	2.66%	$448.43 B	9.80%
NVO	11.00	6.65	60.40%	3.96%	$208.75 B	37.15%
MRK	35.97	7.00	19.45%	2.58%	$321.35 B	13.59%
AZN	25.16	5.22	20.74%	1.89%	$262.79 B	17.02%
GILD	17.55	6.90	39.33%	2.47%	$161.73 B	30.99%
BMY	14.12	5.87	41.59%	3.91%	$131.06 B	18.87%
ZTS	12.23	10.00	81.75%	2.69%	$32.33 B	27.79%
REGN	17.58	2.40	13.65%	0.49%	$76.11 B	27.86%
HALO	27.82	44.19	158.82%	0.00%	$9.70 B	23.13%
AMGN	26.41	22.42	84.87%	2.57%	$206.02 B	20.96%
MCK	22.00	-125.59	-570.98%	0.38%	$104.74 B	1.18%
VRTX	27.75	6.22	22.41%	0.00%	$120.39 B	35.51%
CAH	34.61	-20.14	-58.20%	0.89%	$53.82 B	0.62%
HRMY	13.88	2.22	16.00%	0.00%	$2.02 B	16.20%
BIIB	36.30	1.61	4.43%	0.00%	$30.30 B	8.32%
MEDP	32.46	36.77	113.29%	0.00%	$15.95 B	17.67%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

CDMO Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	03/15/2018	04/02/2018	0.65600000

ABOUT Avid Bioservices

Avid Bioservices Inc.

Average Investor10 user rating

4.0 (0 people)

United States

45 years

Founded: 1981

1988

Time since IPO - 38 years

227

Employees

Avid Bioservices Inc. (United States) is listed on the Nasdaq and has a market capitalization of $799.36 million, with shareholders equity totaling $44.81 million.

The company employs approximately 227 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Avid Bioservices Inc. reported $159.61 million in revenue, generating net income of $-269.14 million.

Key financial metrics include a P/E ratio of -5.26, a price-to-book (P/B) ratio of 17.84, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker CDMO.

Market cap

$799.36 million

Net worth

$44.81 million

$44,810,000.00

Assets

$323.48 million

$323,480,000.00

Total Shares Outstanding

64.00 million

64,000,000

Average Daily Trading Volume

$1.26 million

$1,259,058.12

Sector

Health Care

Industry

Biotechnology

CDMO

CDMO revenue and profits

Financial Results CDMO

DRAG THE FRAME TO SEE MORE DATA

CDMO cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$856.19 23,16% (12M)

P/E

22.00

0.38%

ROE

-570.98%

P/BV

-125.59

CAH - Cardinal Health

$230.03 49,01% (12M)

P/E

34.61

0.89%

ROE

-58.20%

P/BV

-20.14

JNJ - Johnson & Johnson

$256.35 57,85% (12M)

P/E

29.40

2.04%

ROE

24.76%

P/BV

7.28

ABBV - AbbVie

$250.94 33,78% (12M)

P/E

71.07

2.66%

ROE

P/BV

0.00

MRK - Merck & Co.

$130.20 70,76% (12M)

P/E

35.97

2.58%

ROE

19.45%

P/BV

7.00

AZN - AstraZeneca

$169.64 16,43% (12M)

P/E

25.16

1.89%

ROE

20.74%

P/BV

5.22

NVO - Novo Nordisk

$47.08 1,12% (12M)

P/E

11.00

3.96%

ROE

60.40%

P/BV

6.65

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$856.19 23,16% (12 M)

P/L

22.00

0.38%

ROE

-570.98%

P/VP

-125.59

CAH - Cardinal Health

$230.03 49,01% (12 M)

P/L

34.61

0.89%

ROE

-58.20%

P/VP

-20.14

JNJ - Johnson & Johnson

$256.35 57,85% (12 M)

P/L

29.40

2.04%

ROE

24.76%

P/VP

7.28

ABBV - AbbVie

$250.94 33,78% (12 M)

P/L

71.07

2.66%

ROE

P/VP

0.00

MRK - Merck & Co.

$130.20 70,76% (12 M)

P/L

35.97

2.58%

ROE

19.45%

P/VP

7.00

AZN - AstraZeneca

$169.64 16,43% (12 M)

P/L

25.16

1.89%

ROE

20.74%

P/VP

5.22

NVO - Novo Nordisk

$47.08 1,12% (12 M)

P/L

11.00

3.96%

ROE

60.40%

P/VP

6.65

Frequently Asked Questions

What is the price of Avid Bioservices (CDMO) today?

A cotação de Avid Bioservices (CDMO) hoje está em US$ 0.00, com uma variação de 0% em relação ao último ano. A cotação de Avid Bioservices (CDMO) iniciou o ano negociando na casa dos US$ 0.00 e hoje está em US$ 0.00. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Avid Bioservices (CDMO) e dados de ações do Ibovespa e mercados internacionais.

Quando Avid Bioservices (CDMO) paga dividendos?

Avid Bioservices (CDMO) não distribuiu dividendos no último ano.

Is Avid Bioservices (CDMO) a good investment?

Atualmente, Avid Bioservices (CDMO) está cotada a US$ 0.00, com um P/L de -5.26, representando um desvio de -991% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 0 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Avid Bioservices (CDMO) stock?

Investir em ações de Avid Bioservices (CDMO) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Avid Bioservices (CDMO) yield today?

A rentabilidade de Avid Bioservices (CDMO) foi de 0.00% no último mês, 0.00% no último ano e 0.00% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Avid Bioservices (CDMO) hoje, o investimento total seria de US$ 0.00, com base na cotação atual de US$ 0.00.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 0.00
Em 5 anos: US$ 0.00
Em 10 anos: US$ 0.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

CDMO

Avid Bioservices Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment CDMO

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

current DY: 0.00%

5-year average DY: 0.00%

type

Ex - Dividend Date

payment date

value

ABOUT Avid Bioservices

Avid Bioservices Inc.

United States

45 years

1988

227

PROFIT X PRICE CDMO

Financial Results CDMO

CDMO cash flow

Asset, Revenue and Profit Growth - CDMO

CDMO balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

NVO - Novo Nordisk

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

NVO - Novo Nordisk

Frequently Asked Questions